Tesoro, Frenz Chandrea T.
HRN: 21-74-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2022
CEFUROXIME 750MG (VIAL)
08/05/2022
08/11/2022
IVT
300mg
Q8
Tonsilitis, Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes